SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-02-000744
Filing Date
2002-02-26
Accepted
2002-02-26 00:00:00
Documents
11
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2001 d10k.txt 10-K 266831
3 AMENDED AND RESTATED BYLAWS OF AMGEN dex32.txt EX-3.2 67461
4 COMPANY'S AMENDED AND RESTATED 1991 EIP dex101.txt EX-10.1 49794
5 COMPANY'S AMENDED & RESTATED 1997 SPECIAL NOEIP dex102.txt EX-10.2 37250
6 AGREEMENT BETWEEN AMGEN & DR. BETH C. SEIDENBERG dex1060.txt EX-10.60 21789
7 AMENDMENT TO AGREEMENT - DR. BETH C. SEIDENBERG dex1061.txt EX-10.61 2133
8 SECOND AMENDMENT TO AMGEN SRP dex1062.txt EX-10.62 4931
9 THIRD AMENDMENT TO AMGEN RSP dex1063.txt EX-10.63 14952
10 AMGEN EXECUTIVE NONQUALIFIED RETIREMENT PLAN dex1064.txt EX-10.64 34827
11 NONQUALIFIED DEFERRED COMPENSATION PLAN dex1065.txt EX-10.65 99246
12 SUBSIDIARIES OF THE COMPANY dex21.txt EX-21 631
  Complete submission text file 0000898430-02-000744.txt   602835
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 02558690
SIC: 2836 Biological Products, (No Diagnostic Substances)